Clinical Trial Update: A Pilot Study of KRX-0502 (Ferric Citrate, Administered Without Food, in Treating Iron-deficiency Anemia [Phase 2]

View source ↗

Summary

Phase 2 pilot study of KRX-0502 (ferric citrate) administered without food for iron-deficiency anemia in chronic kidney disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• KRX-0502 (Ferric citrate)

Snippet

Sponsor: Keryx Biopharmaceuticals | Conditions: Anemia of Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-08-24